Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
QSIF Equity Ex-Top 100 Long-Short Fund Reg (G)
[SIF: Equity LS]  
 
Fund Details
Fund Type Growth Launch Date 24-Oct-25
Corpus(Cr.) 1110.00 Latest NAV 10.9944 As on 29-10-2026
Equity(%) 74.32 52 Week High 11.5773
Debt(%) 25.68 52 Week Low 8.5587
Others(%) 0.00 Exit Load 3% if redeemed/switched out on or before completion of 30 days from the date of allotment of units. No Exit Load is payable if Units are redeemed / switched-out after 30 days from the date of allotment
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.90
Scheme Benchmark Nifty 500 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sandeep Tandon
 
Riskometer
Investors understand that their principal will be at Moderately High risk
 
Scheme Objective
To generate long-term capital appreciaon by invesng primarily in equity and equityrelated instruments of stocks outside the top 100 by market capitalizaon, while ulizing limited short exposure through derivaves to enhance returns and manage risk. There is no assurance that t h e i nv e s t m e n t o b j e c v e o f t h e Investment strategy will be achieved.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 53.07%
Top 10 Holdings 72.91%
Top 25 Holdings 107.67%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Cash 21.17
Pharma & Biotech 14.88
Telecom 9.21
Derivatives 7.3
Banking & Financial 6.89
SOV 4.51
Oil & GAS 4.38
Consumer Durables 4.14
Finance & Investments 3.97
Healthcare 3.89
Aerospace & Defence 3.89
Automobile 3.61
Transportation 3.28
Miscellaneous 2.78
FMCG 2.4
Industrial Products 1.74
Construction 1.02
Software & Services 0.57
Energy 0.3
Agricultural & Farm Machinery 0.07
 
 
 
 
 
Portfolio Metrics
PB Ratio 0.00
PE Ratio 0.00
 
Top 25 Holdings
Holdings Net Asset(%)
TREPS 01-Oct-2026 DEPO 10 29.39
INDUS TOWERS LIMITED 9.21
Gujarat Themis Biosyn Ltd. 5.24
National Stock Exchange of India Limited 4.89
Zydus Lifesciences Limited 4.34
LG Electronics India Limited 4.14
Piramal Finance Limited 3.97
GlaxoSmithkline Pharmaceuticals Ltd. 3.95
Aequs Limited 3.89
Indegene Limited 3.89
Glenmark Pharmaceuticals Ltd. 3.51
Sona BLW Precision Forgings Limited 3.40
Container Corporation Of India Ltd. 3.28
LIFE INSURANCE CORPORATION OF INDIA 2.78
Coal India Ltd. 2.74
Multi Commodity Exchange of India Ltd. 2.62
LTM Ltd. 2.49
Colgate-Palmolive (India) Ltd. 2.40
Caliber Mining and Logistics Limited 2.26
NIPPON LIFE INDIA ASSET MANAGEMENT LIMITED 2.00
Indo Mim Ltd 1.74
Aurobindo Pharma Ltd. 1.66
Info Edge (India) Ltd. 1.39
Pfizer Ltd. 1.35
Vedanta Oil and Gas Limited 1.14

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.22% 1.21% 11.92% 9.94%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty 500 TRI]
-0.68% -5.86% -3.43% -7.59%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
0.00% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
-0.95% 10.39% 8.85% 12.54%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection